Pfizer begins trial of Omicron specific jab
Pfizer has started clinical trials on a Omicron tailored version of its COVID vaccine. US health officials believe the variant will be the dominant strain in the community for some time and a targeted vaccine will be beneficial as a booster.
UP NEXT
NOW PLAYING: news
Pfizer begins trial of Omicron specific jab
ABC NEWS
UP NEXT
-
Incredible tap sets up Naughton goal
9News.com.au
-
Company behind WA boating incident says vessel didn't capsize
-
Police searching for three men following home invasion
-
Man dies in police custody
-
Greens candidate claims victory in seat of Brisbane
-
Outpouring of grief after Sunshine Coast woman shot dead
-
Policewoman fires gun after constable allegedly mowed down
-
Battle over proposed waste facility
-
CCTV released of six men linked to serious Sydney assault
-
Police made 'wrong decision' during school shooting
-
Joyce faces leadership challenge from his number two
-
Australian aid worker killed during Russian invasion of Ukraine
-
Young people using sport to connect in remote Australia
ABC NEWS
-
Man dies when police intervene in Adelaide fight
-
Abattoir workers sing to handle homesickness
-
Calls for change in pet policy for WA rental properties
